We’re a Tokyo-based biotech company on a mission to address unmet medical needs with an innovative, patient-friendly therapy for a wide range of cancers—including those that are hard to treat. Our lead asset is Panectin®, an oncolytic virus therapy.
We’re a Tokyo-based biotech company on a mission to address unmet medical needs with an innovative, patient-friendly therapy for a wide range of cancers—including those that are hard to treat. Our lead asset is Panectin®, an oncolytic virus therapy.